Search results for "new drug development"

South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway

South Korea Ranks in GSK’s Global Top 10 for Clinical Research, with Over 70 Trials Underway

"South Korea is among the top 10 markets in GSK’s global clinical research. More than 70 clinical programs are currently underway here.
Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology

Daegu Wins Bid to Host 2034 World Congress of Basic & Clinical Pharmacology

Daegu has been selected to host the 2034 World Congress of Basic & Clinical Pharmacology (WCP 2034), marking the first time South Korea will hold the...
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals

Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals

The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...
Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development

Why Surgeons are Tracking the Rise of 'Pharmulator': The Next Frontier in Drug Development

The new drug development platform Pharmulator™ has officially made its debut on the international stage—not at a...
Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won

Exclusive: Boryung’s Spun-Off Sales Unit Sets Pay Above Parent Levels, Top 40% Eligible for 100 Million-Plus Won

Boryung is setting compensation at its soon-to-be spun-off prescription drug sales division above parent-company...
‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital

‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital

Global life sciences investment firm Novo Holdings is bringing its proven European biotech company-building playbook to...
“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families

“I Dream of an Ordinary Life”: Expanded Insurance Coverage Brings New Hope to Dravet Syndrome Families

“Until just before my daughter turned 2, she frequently suffered not only febrile seizures but also afebrile seizures.
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group

Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells

South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.